Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP2151 in Recurrent Genital Herpes
NCT00486200Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Amenamevir in genital herpes, sponsored by Astellas Pharma. Started Jun 2007; status: completed.
02
Drugs
Amenamevir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00486200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486200.